Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
IFS Transcript
Intercorp Financial Services Inc. (IFS) Q1 2026 Earnings Call Transcript
Positive5-12
The earnings call highlights strong financial performance with a 10% revenue increase and a 15% rise in net income, driven by higher loan volumes and improved net interest margins. The loan portfolio's 12% growth and improved ROE to 18% are promising. Despite a 5% rise in operating expenses, these investments support digital transformation. The absence of negative insights from the Q&A suggests a generally positive sentiment. Given the company's market cap of $2.55 billion, these positive indicators suggest a likely positive stock price movement in the next two weeks.
Intercorp Financial Services Inc. (IFS) Q4 2025 Earnings Call Transcript
Positive2-12
The earnings call highlights strong financial metrics, including 11% growth in retail primary banking customers and a 61% increase in insurance premiums. The Q&A reveals management's confidence in handling risks and achieving growth, despite political uncertainties. The company's focus on digital strategy and sustainable loan portfolios further supports a positive outlook. While there are concerns about market share loss and political risks, the overall sentiment remains positive, indicating a likely stock price increase in the short term.
Intercorp Financial Services Inc. (IFS) Q3 2025 Earnings Call Transcript
Positive11-7
The earnings call presents strong financial performance with significant net income growth, improved NIM, and low cost of risk. Despite some uncertainties like the Rutas de Lima impairment, the impact is minimal. Positive trends in loan portfolio growth, insurance premiums, and wealth management assets support a favorable outlook. Additionally, strategic investments and digital engagement indicate a robust future. While management's vague responses on certain issues may raise concerns, the overall sentiment is positive, suggesting a likely stock price increase of 2% to 8%.
Intercorp Financial Services Inc. (IFS) Q2 2025 Earnings Call Transcript
Positive8-15
The earnings call reveals strong financial performance, including a significant increase in net income and ROE, improved cost of risk, and growth in retail banking customers. Despite a slight decline in loan yields, other financial metrics like AUM and insurance premiums show robust growth. The Q&A session supports this positive outlook, with expectations for improved NIM and manageable OpEx growth. The market cap indicates a potential positive reaction, likely in the 2% to 8% range, given the overall strong financial health and optimistic guidance.
IFS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
